INZY Financial Statements

Balance sheet, income statement, cash flow, and dividends for Inozyme Pharma Inc (INZY).


$177.95M Market Cap.

As of 03/11/2025 5:00 PM ET (MRY) • Disclaimer

INZY Market Cap. (MRY)


INZY Shares Outstanding (MRY)


INZY Assets (MRY)


Total Assets

$123.18M

Total Liabilities

$65.36M

Total Investments

$92.01M

INZY Income (MRY)


Revenue

$0

Net Income

-$102.02M

Operating Expense

$104.03M

INZY Cash Flow (MRY)


CF Operations

-$91.91M

CF Investing

$67.00M

CF Financing

$11.40M

INZY Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

INZY Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$123,182,000 (-38.67%)

$200,847,000 (44.29%)

$139,195,000 (12.67%)

$123,541,000 (-27.06%)

Assets Current

$120,676,000 (-38.51%)

$196,250,000 (49.36%)

$131,393,000 (13.92%)

$115,342,000 (-23.60%)

Assets Non-Current

$2,506,000 (-45.49%)

$4,597,000 (-41.08%)

$7,802,000 (-4.84%)

$8,199,000 (-55.40%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$57,826,000 (-58.84%)

$140,479,000 (18.65%)

$118,394,000 (8.35%)

$109,268,000 (-30.89%)

Property Plant & Equipment Net

$1,346,000 (-48.07%)

$2,592,000 (-28.75%)

$3,638,000 (-17.99%)

$4,436,000 (67.52%)

Cash & Equivalents

$21,392,000 (-38.70%)

$34,899,000 (4.90%)

$33,269,000 (42.69%)

$23,316,000 (-17.88%)

Accumulated Other Comprehensive Income

$69,000 (68.29%)

$41,000 (120.00%)

-$205,000 (-1238.89%)

$18,000 (800.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$92,006,000 (-40.26%)

$154,001,000 (62.19%)

$94,951,000 (7.31%)

$88,485,000 (-32.89%)

Investments Current

$92,006,000 (-40.26%)

$154,001,000 (62.19%)

$94,951,000 (7.31%)

$88,485,000 (-26.05%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,530,000 (116.98%)

$1,166,000 (-54.17%)

$2,544,000 (6.27%)

$2,394,000 (-21.99%)

Accumulated Retained Earnings (Deficit)

-$387,954,000 (-35.68%)

-$285,930,000 (-33.14%)

-$214,761,000 (-45.40%)

-$147,700,000 (-62.17%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$46,873,000 (0.60%)

$46,592,000 (587.40%)

$6,778,000 (101.07%)

$3,371,000 (161.93%)

Debt Current

$15,415,000 (1593.96%)

$910,000 (11.52%)

$816,000 (11.63%)

$731,000 (0%)

Debt Non-Current

$31,458,000 (-31.14%)

$45,682,000 (666.22%)

$5,962,000 (125.83%)

$2,640,000 (105.13%)

Total Liabilities

$65,356,000 (8.26%)

$60,368,000 (190.22%)

$20,801,000 (45.74%)

$14,273,000 (26.76%)

Liabilities Current

$33,898,000 (130.82%)

$14,686,000 (-0.20%)

$14,715,000 (26.49%)

$11,633,000 (16.64%)

Liabilities Non-Current

$31,458,000 (-31.14%)

$45,682,000 (650.61%)

$6,086,000 (130.53%)

$2,640,000 (105.13%)

INZY Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$20,799,000 (0.00%)

$20,798,000 (-0.13%)

$20,826,000 (10.04%)

$18,926,000 (79.43%)

Research & Development Expense

$83,231,000 (51.75%)

$54,847,000 (14.63%)

$47,849,000 (26.85%)

$37,720,000 (-18.87%)

Operating Expenses

$104,030,000 (37.52%)

$75,645,000 (10.15%)

$68,675,000 (21.24%)

$56,646,000 (-0.69%)

Interest Expense

$5,558,000 (66.76%)

$3,333,000 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$102,024,000 (-43.35%)

-$71,169,000 (-6.13%)

-$67,061,000 (-18.43%)

-$56,624,000 (-0.35%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$102,024,000 (-43.35%)

-$71,169,000 (-6.13%)

-$67,061,000 (-18.43%)

-$56,624,000 (-0.35%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$102,024,000 (-43.35%)

-$71,169,000 (-6.13%)

-$67,061,000 (-18.43%)

-$56,624,000 (-0.35%)

Weighted Average Shares

$62,811,814 (21.17%)

$51,839,131 (37.27%)

$37,763,168 (60.30%)

$23,558,306 (113.46%)

Weighted Average Shares Diluted

$62,811,814 (21.17%)

$51,839,131 (37.27%)

$37,763,168 (60.30%)

$23,558,306 (113.46%)

Earning Before Interest & Taxes (EBIT)

-$96,466,000 (-42.20%)

-$67,836,000 (-1.16%)

-$67,061,000 (-18.43%)

-$56,624,000 (-0.35%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$104,030,000 (-37.52%)

-$75,645,000 (-10.15%)

-$68,675,000 (-21.24%)

-$56,646,000 (0.69%)

INZY Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$66,998,000 (224.89%)

-$53,646,000 (-892.89%)

-$5,403,000 (-112.63%)

$42,796,000 (136.52%)

Net Cash Flow from Financing

$11,398,000 (-90.95%)

$125,969,000 (73.06%)

$72,788,000 (11852.05%)

$609,000 (-99.59%)

Net Cash Flow from Operations

-$91,907,000 (-30.04%)

-$70,675,000 (-22.36%)

-$57,761,000 (-19.95%)

-$48,153,000 (-33.86%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$13,511,000 (-919.84%)

$1,648,000 (-82.88%)

$9,624,000 (302.70%)

-$4,748,000 (-42.11%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$67,060,000 (225.70%)

-$53,348,000 (-968.46%)

-$4,993,000 (-111.56%)

$43,193,000 (137.04%)

Capital Expenditure

-$62,000 (79.19%)

-$298,000 (27.32%)

-$410,000 (-3.27%)

-$397,000 (30.11%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$40,000,000 (887.65%)

$4,050,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$11,398,000 (-86.74%)

$85,969,000 (25.07%)

$68,738,000 (11187.03%)

$609,000 (-99.48%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$4,000 (122.22%)

-$18,000 (28.00%)

-$25,000 (-204.17%)

$24,000 (0%)

Share Based Compensation

$7,945,000 (12.90%)

$7,037,000 (-8.28%)

$7,672,000 (7.09%)

$7,164,000 (210.40%)

Depreciation Amortization & Accretion

$1,306,000 (-1.58%)

$1,327,000 (12.74%)

$1,177,000 (11.88%)

$1,052,000 (384.79%)

INZY Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-115.30% (-106.26%)

-55.90% (-3.52%)

-54.00% (-24.42%)

-43.40% (54.79%)

Return on Average Assets (ROAA)

-68.10% (-67.32%)

-40.70% (14.32%)

-47.50% (-19.35%)

-39.80% (19.11%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-61.90% (-40.68%)

-44.00% (40.78%)

-74.30% (-48.90%)

-49.90% (40.74%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.71 (45.00%)

-3.11 (-426.95%)

-0.59 (79.24%)

-2.84 (29.64%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

3.08 (64.28%)

1.87 (423.18%)

0.36 (-75.76%)

1.48 (-51.59%)

Debt to Equity Ratio (D/E)

1.13 (162.79%)

0.43 (144.32%)

0.18 (34.35%)

0.13 (84.51%)

Earnings Per Share (EPS)

-1.62 (-18.25%)

-1.37 (23.03%)

-1.78 (25.83%)

-2.4 (53.03%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.46 (-6.94%)

-1.37 (11.10%)

-1.54 (25.28%)

-2.06 (37.75%)

Book Value Per Share (BVPS)

0.92 (-66.01%)

2.71 (-13.56%)

3.13 (-32.41%)

4.64 (-67.62%)

Tangible Assets Book Value Per Share (TABVPS)

1.96 (-49.38%)

3.87 (5.10%)

3.69 (-29.71%)

5.24 (-65.83%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (50.00%)

-4 (0%)

0 (0%)

-2 (75.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.1 (44.13%)

-3.76 (-4598.75%)

-0.08 (96.76%)

-2.47 (67.19%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

3.56 (-73.36%)

13.36 (49.66%)

8.93 (-9.94%)

9.91 (-34.51%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$91,969,000 (-29.58%)

-$70,973,000 (-22.01%)

-$58,171,000 (-19.82%)

-$48,550,000 (-32.86%)

Enterprise Value (EV)

$199,851,348 (-20.06%)

$249,994,786 (4641.86%)

$5,272,081 (-96.16%)

$137,350,575 (-67.57%)

Earnings Before Tax (EBT)

-$102,024,000 (-43.35%)

-$71,169,000 (-6.13%)

-$67,061,000 (-18.43%)

-$56,624,000 (-0.35%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$95,160,000 (-43.08%)

-$66,509,000 (-0.95%)

-$65,884,000 (-18.56%)

-$55,572,000 (1.13%)

Invested Capital

$114,765,000 (-42.00%)

$197,854,000 (101.91%)

$97,989,000 (6.55%)

$91,963,000 (-30.48%)

Working Capital

$86,778,000 (-52.21%)

$181,564,000 (55.61%)

$116,678,000 (12.51%)

$103,709,000 (-26.45%)

Tangible Asset Value

$123,182,000 (-38.67%)

$200,847,000 (44.29%)

$139,195,000 (12.67%)

$123,541,000 (-27.06%)

Market Capitalization

$177,945,348 (-32.37%)

$263,100,786 (520.31%)

$42,414,081 (-73.72%)

$161,393,575 (-66.54%)

Average Equity

$88,467,500 (-30.56%)

$127,408,000 (2.63%)

$124,144,750 (-4.94%)

$130,601,250 (122.11%)

Average Assets

$149,799,500 (-14.31%)

$174,818,500 (23.95%)

$141,034,000 (-0.76%)

$142,115,250 (23.87%)

Invested Capital Average

$155,817,000 (1.10%)

$154,120,500 (70.72%)

$90,278,000 (-20.50%)

$113,557,500 (69.40%)

Shares

64,240,198 (4.01%)

61,760,748 (52.89%)

40,394,363 (70.69%)

23,664,747 (1.25%)